Evaluation of a pilot study to influence medication adherence of patients with diabetes mellitus type-2 by the pharmacy

Adhien, Prem; Dijk, Liset van; Vegter, M.; Westein, Marnix P.D.; Nijpels, Giel; Hugtenburg, Jacqueline G.

doi:10.1007/s11096-013-9834-4

Cited by 10 publications

(22 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this implementation, the systematization of actions and the uptake of the team were important to envision the maintenance of the program in a long-term perspective. This is aligned with the literature [ 10 , 12 ]. Despite the encountered barriers, healthcare professionals continued to deliver the program and wanted to extend it to other pathologies.…”

Section: Discussionsupporting

confidence: 90%

“…The lack of motivation and the lack of benefits perceived by healthcare professionals are barriers that limit the adoption of these new services [ 2 , 8 , 11 ]. Moreover, external factors such as the patients’ needs and acceptance/perception, the lack of collaboration, and the opinion of other healthcare professionals also influence the implementation of new services [ 8 , 10 , 12 , 13 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Implementation study of an interprofessional medication adherence program for HIV patients in Switzerland: quantitative and qualitative implementation results

Lelubre

Clerc

Grosjean

et al. 2018

BMC Health Serv Res

View full text Add to dashboard Cite

BackgroundAn interprofessional medication adherence program (IMAP) for chronic patients was developed and successfully implemented in the community pharmacy of the Department of ambulatory care and community medicine (Lausanne, Switzerland). This study assesses the capacity of a physician and a nurse at the infectious diseases service of a public hospital and of community pharmacists in the Neuchâtel area (Switzerland) to implement the IMAP in their practice.MethodsMixed method, prospective, observational study. Quantitative and qualitative analyses of the implementation process were conducted following the RE-AIM model (reach, effectiveness, adoption, implementation and maintenance).ResultsImplementation started in November 2014. One physician, one nurse, and five pharmacists agreed to participate. Healthcare professionals perceived the benefits of the program and were motivated to implement it in their practice (adoption). Seventeen patients were included in the program; 13 refused to participate. The inclusion of naïve HIV patients was easier than the inclusion of experienced patients with difficult psychosocial issues (reach). Pharmacists were engaged in reinforcing patient medication adherence in 25% of interviews (effectiveness). Key facilitators expressed by healthcare professionals were patient inclusion by the physician and the nurse instead of the pharmacist and the organisation of regular meetings between all stakeholders. In contrast, the encountered barriers were the lack of time and resources, the lack of team uptake, and the lack of adoption by senior managers (implementation). Interviewed patients were all satisfied with this new program, encouraging healthcare professionals to scale it up. Structural changes allowed the hospital and one pharmacy to enter the maintenance stage (maintenance).ConclusionThe research team and collaboration between all professionals involved played an important role in this implementation. However, the dissemination of such a program to a larger scale and for the long term requires financial and structural resources as well as transitional external support.Electronic supplementary materialThe online version of this article (10.1186/s12913-018-3641-5) contains supplementary material, which is available to authorized users.

show abstract

Section: Discussionsupporting

confidence: 90%

Section: Introductionmentioning

confidence: 99%

Implementation study of an interprofessional medication adherence program for HIV patients in Switzerland: quantitative and qualitative implementation results

Lelubre

Clerc

Grosjean

et al. 2018

BMC Health Serv Res

View full text Add to dashboard Cite

show abstract

“…5,25,26 Seven studies evaluated the use of pharmacy technicians in advanced roles and as part of team-based interventions. [27][28][29][30][31][32][33]…”

Section: Resultsmentioning

confidence: 99%

“…Although no studies have specifically evaluated the role of pharmacy technicians in onychomycosis treatment, other studies have shown the benefits of utilizing pharmacy technicians for improving outcomes in other disease states, such as hypertension and diabetes. 29,30 Pharmacy technicians can identify patients at risk for poor adherence and adverse reactions. [29][30][31] The use of a team approach involving pharmacy technicians can improve refill rates and adherence.…”

Section: Discussionmentioning

confidence: 99%

Pharmacy Technicians and Improving Onychomycosis Treatment Outcomes

Brown

2018

Journal of Pharmacy Technology

View full text Add to dashboard Cite

English-language articles on onychomycosis and onychomycosis treatment were identified through searches conducted using MEDLINE/PubMed (1966 to October 2018). The keywords "onychomycosis," "onychomycosis treatment," and onychomycosis prevention" were used in addition to the following medical subject headings: "Onychomycosis/complications," "Onychomycosis/ drug therapy," "Onychomycosis/prevention and control," and "Onychomycosis/therapy." "Pharmacist," "pharmacy technician," and "pharmacy" were used to locate articles addressing the impact of pharmacists and pharmacy technicians on onychomycosis treatment outcomes. Reference lists of relevant articles were searched for 815057P MTXXX10.

show abstract

“…This overview can be used as an action plan. The intervention programme and materials are partly based upon the promising results of a previous study in which the feasibility of a modular intervention programme in patients with diabetes was evaluated [29]. On top of that, the intervention materials (the QBS and the TIG) were further developed based upon our own research including a systematic literature review and a cross-sectional study (manuscripts in preparation).…”

Section: Methodsmentioning

confidence: 99%

The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial

Laan

Elders

Boons

et al. 2017

Trials

Self Cite

View full text Add to dashboard Cite

BackgroundMedication non-adherence is a complex health care problem. Due to non-adherence, substantial numbers of cardiovascular patients benefit from their medication to only a limited extent. In order to improve adherence, a variety of pharmacist-led interventions have been developed. However, even the most effective interventions achieved only a modest positive effect. To be effective, interventions should be targeted at underlying barriers to adherence, developed in a systematic manner and tailored to specific features of a target group and setting. The current paper describes the design of the Cardiovascular medication non-Adherence Tailored Intervention (CATI) study aimed to evaluate the (cost-)effectiveness of a patient-tailored intervention programme in patients using antihypertensive medication.MethodsThe CATI study is a randomised controlled trial that will be performed in 13 community pharmacies. Patients aged 45–75 years using antihypertensive medication and considered non-adherent according to pharmacy dispensing data, as well according to a self-report questionnaire, are eligible to participate. Patients in the intervention condition will receive a patient-tailored, pharmacist-led intervention programme. This programme consists of a structured interview at the pharmacy to identify patients’ barriers to adherence and to counsel patients in order to overcome these barriers. The primary outcome is self-reported medication adherence measured with the MARS-5 questionnaire. Secondary outcome measures are blood pressure, illness perceptions, quality of life and societal costs. A cost-effectiveness analysis and process evaluation will also be performed.DiscussionThis study will provide insight into the (cost-)effectiveness of a patient-tailored, pharmacist-led intervention programme in non-adherent patients using antihypertensive medication. This intervention programme allows community pharmacists to support their patients in overcoming barriers to adherence and improving medication adherence in a structured and patient-tailored manner. An effective intervention will not only enhance medication adherence, but may also improve health outcomes and decrease health care utilisation and costs.Trial registrationNetherlands Trial Register (identifier: NTR5017), registered on 2 February 2015.Electronic supplementary materialThe online version of this article (doi:10.1186/s13063-016-1696-3) contains supplementary material, which is available to authorized users.

show abstract

Evaluation of a pilot study to influence medication adherence of patients with diabetes mellitus type-2 by the pharmacy

Cited by 10 publications

References 17 publications

Implementation study of an interprofessional medication adherence program for HIV patients in Switzerland: quantitative and qualitative implementation results

Implementation study of an interprofessional medication adherence program for HIV patients in Switzerland: quantitative and qualitative implementation results

Pharmacy Technicians and Improving Onychomycosis Treatment Outcomes

The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial

Contact Info

Product

Resources

About